Literature DB >> 15350841

Statins inhibit reoxygenation-induced cardiomyocyte apoptosis: role for glycogen synthase kinase 3beta and transcription factor beta-catenin.

Martin W Bergmann1, Cindy Rechner, Christian Freund, Anthony Baurand, Amina El Jamali, Rainer Dietz.   

Abstract

BACKGROUND: Statins may improve left ventricular remodeling after myocardial infarction. We tested whether statins inhibit cardiomyocyte apoptosis through glycogen synthase kinase 3beta (GSK3beta) inactivation and evaluated activation of downstream transcription factors. METHODS/
RESULTS: Mevastatin and pravastatin activated serine/threonine kinase Akt in neonatal cardiomyocytes dose and time dependently with maximal activation at 15 min/10 microM. Caspase-3 activity was induced 2.73 +/- 0.29-fold by 6 h of hypoxia followed by 18 h of reoxygenation. Pravastatin added at the beginning of the reoxygenation period reduced caspase-3 activation to 1.26 +/- 0.06-fold compared to control cells (P < 0.001). Similar results were obtained for mevastatin (decreased to 1.98 +/- 0.45-fold, P < 0.05). TUNEL staining of neonatal cardiomyocytes after 24 h reoxygenation and 4',6'-diamidino-2-phenylindole staining of adult rat cardiomyocytes after 6 h H(2)O(2) showed reduced cardiomyocyte apoptosis in the presence of statin. Analysis of signaling pathways downstream of Akt revealed phosphorylation of GSK3beta. Transcription factor cAMP-responsive element binding (CREB) protein showed weak phosphorylation at serine 133; transcription factor NF-kappaB was not significantly activated after statin treatment as evaluated by EMSA. The GSK3beta target protein beta-catenin was stabilized at 3 h after statin treatment both in neonatal as well as adult rat cardiomyocytes. Transfection with constitutive active GSK3betaS9A sensitized neonatal cardiomyocytes to hypoxia/reoxygenation-induced apoptosis as measured by annexin V/propidium iodide staining. Furthermore, myocardial protein extracts of mice revealed GSK3beta inactivation after administration of pravastatin intraperitoneally.
CONCLUSIONS: Statins inhibit cardiomyocyte apoptosis in association with GSK3beta inactivation. Inactivation of GSK3beta leads to stabilization of beta-catenin in cardiomyocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15350841     DOI: 10.1016/j.yjmcc.2004.05.025

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  19 in total

Review 1.  Winding through the WNT pathway during cellular development and demise.

Authors:  F Li; Z Z Chong; K Maiese
Journal:  Histol Histopathol       Date:  2006-01       Impact factor: 2.303

2.  Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair.

Authors:  Maria Mirotsou; Zhongyan Zhang; Arjun Deb; Lunan Zhang; Massimiliano Gnecchi; Nicolas Noiseux; Hui Mu; Alok Pachori; Victor Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-24       Impact factor: 11.205

Review 3.  The Wnt signaling pathway: aging gracefully as a protectionist?

Authors:  Kenneth Maiese; Faqi Li; Zhao Zhong Chong; Yan Chen Shang
Journal:  Pharmacol Ther       Date:  2008-02-11       Impact factor: 12.310

4.  Ginsenoside Rb1 protects cardiomyocytes against CoCl2-induced apoptosis in neonatal rats by inhibiting mitochondria permeability transition pore opening.

Authors:  Hong-liang Kong; Zhan-quan Li; Ying-jun Zhao; Shu-mei Zhao; Li Zhu; Tong Li; Yao Fu; Hui-jun Li
Journal:  Acta Pharmacol Sin       Date:  2010-06       Impact factor: 6.150

5.  A cell-based phenotypic assay to identify cardioprotective agents.

Authors:  Stephanie Guo; Adam Olm-Shipman; Andrew Walters; William R Urciuoli; Stefanie Devito; Sergiy M Nadtochiy; Andrew P Wojtovich; Paul S Brookes
Journal:  Circ Res       Date:  2012-03-06       Impact factor: 17.367

6.  Canonical wnt signaling regulates extracellular matrix expression in the trabecular meshwork.

Authors:  Guadalupe Villarreal; Ayan Chatterjee; Sarah S Oh; Dong-Jin Oh; Min Hyung Kang; Douglas J Rhee
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-28       Impact factor: 4.799

7.  TWEAK protects cardiomyocyte against apoptosis in a PI3K/AKT pathway dependent manner.

Authors:  Bin Yang; Ping Yan; Hui Gong; Lin Zuo; Ying Shi; Jian Guo; Rui Guo; Jun Xie; Bao Li
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

8.  Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta.

Authors:  Anindita Das; Lei Xi; Rakesh C Kukreja
Journal:  J Biol Chem       Date:  2008-08-21       Impact factor: 5.157

9.  Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation.

Authors:  Shin-ichi Tanaka; Yoshihiro Fukumoto; Kotaro Nochioka; Tatsuro Minami; Shun Kudo; Nobuyuki Shiba; Yoshimi Takai; Carol L Williams; James K Liao; Hiroaki Shimokawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-05-02       Impact factor: 8.311

Review 10.  Intervention for apoptosis in cardiomyopathy.

Authors:  Hiroyuki Yaoita; Yukio Maruyama
Journal:  Heart Fail Rev       Date:  2008-06       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.